Wesley Wang
Overview
Explore the profile of Wesley Wang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
208
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Angello N, Friday D, Hwang C, Yi S, Cheng A, Torres-Flores T, et al.
Nature
. 2024 Aug;
633(8029):351-358.
PMID: 39198655
Artificial intelligence-guided closed-loop experimentation has emerged as a promising method for optimization of objective functions, but the substantial potential of this traditionally black-box approach to uncovering new chemical knowledge has...
2.
Strieth-Kalthoff F, Hao H, Rathore V, Derasp J, Gaudin T, Angello N, et al.
Science
. 2024 May;
384(6697):eadk9227.
PMID: 38753786
Contemporary materials discovery requires intricate sequences of synthesis, formulation, and characterization that often span multiple locations with specialized expertise or instrumentation. To accelerate these workflows, we present a cloud-based strategy...
3.
Joana Alves M, Browe B, Carolina Rodrigues Dias A, Torres J, Zaza G, Bangudi S, et al.
Brain Behav Immun
. 2024 Apr;
119:333-350.
PMID: 38561095
Neonatal sepsis remains one of the leading causes of mortality in newborns. Several brainstem-regulated physiological processes undergo disruption during neonatal sepsis. Mechanistic knowledge gaps exist at the interplay between metabolism...
4.
Wang W, Kumm Z, Ho C, Zanesco-Fontes I, Texiera G, Reis R, et al.
Neurooncol Adv
. 2024 Feb;
6(1):vdad140.
PMID: 38405202
Background: Glioblastoma is a malignant brain tumor requiring careful clinical monitoring even after primary management. Personalized medicine has suggested the use of various molecular biomarkers as predictors of patient prognosis...
5.
Wang W, Tugaoen J, Fadda P, Toland A, Ma Q, Elder J, et al.
Acta Neuropathol Commun
. 2023 Dec;
11(1):192.
PMID: 38049893
Post-resection radiologic monitoring to identify areas of new or progressive enhancement concerning for cancer recurrence is critical during patients with glioblastoma follow-up. However, treatment-related pseudoprogression presents with similar imaging features...
6.
Alban T, Grabowski M, Otvos B, Bayik D, Wang W, Zalavadia A, et al.
JCI Insight
. 2023 May;
8(13).
PMID: 37252795
Intratumoral heterogeneity is a defining hallmark of glioblastoma, driving drug resistance and ultimately recurrence. Many somatic drivers of microenvironmental change have been shown to affect this heterogeneity and, ultimately, the...
7.
Wang W, Kumm Z, Ho C, Zanesco-Fontes I, Texiera G, Reis R, et al.
Res Sq
. 2023 May;
PMID: 37131745
Purpose: Glioblastoma is a malignant brain tumor requiring careful clinical monitoring even after primary management. Personalized medicine has suggested use of various molecular biomarkers as predictors of patient prognosis or...
8.
Rajendran S, Hu Y, Canella A, Peterson C, Gross A, Cam M, et al.
Cell Rep
. 2023 Mar;
42(3):112197.
PMID: 36871221
Recent studies have shown the importance of the dynamic tumor microenvironment (TME) in high-grade gliomas (HGGs). In particular, myeloid cells are known to mediate immunosuppression in glioma; however, it is...
9.
Wang W, Howard D, Giglio P, Thomas D, Otero J
Neuro Oncol
. 2022 Apr;
24(6):853-854.
PMID: 35381085
No abstract available.
10.
Blair D, Chitti S, Trobe M, Kostyra D, Haley H, Hansen R, et al.
Nature
. 2022 Feb;
604(7904):92-97.
PMID: 35134814
Fully automated synthetic chemistry would substantially change the field by providing broad on-demand access to small molecules. However, the reactions that can be run autonomously are still limited. Automating the...